Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial

Peter Horby, Marion Mafham, Louise Linsell, Jennifer L Bell, Natalie Staplin, Jonathan R Emberson, Martin Wiselka, Andrew Ustianowski, Einas Elmahi, Benjamin Prudon, Anthony Whitehouse, Timothy Felton, John Williams, Jakki Faccenda, Jonathan Underwood, J Kenneth Baillie, Lucy Chappell, Saul N Faust, Thomas Jaki, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Kathryn Rowan, Joel Tarning, James A Watson, Nicholas J White, Edmund Juszczak, Richard Haynes, Martin J Landray
doi: https://doi.org/10.1101/2020.07.15.20151852

Article Information

doi 
https://doi.org/10.1101/2020.07.15.20151852
History 
  • July 15, 2020.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Peter Horby1,
  2. Marion Mafham2,
  3. Louise Linsell2,
  4. Jennifer L Bell2,
  5. Natalie Staplin3,
  6. Jonathan R Emberson3,
  7. Martin Wiselka4,
  8. Andrew Ustianowski5,
  9. Einas Elmahi6,
  10. Benjamin Prudon7,
  11. Anthony Whitehouse8,
  12. Timothy Felton9,
  13. John Williams10,
  14. Jakki Faccenda11,
  15. Jonathan Underwood12,
  16. J Kenneth Baillie13,
  17. Lucy Chappell14,
  18. Saul N Faust15,
  19. Thomas Jaki16,
  20. Katie Jeffery17,
  21. Wei Shen Lim18,
  22. Alan Montgomery19,
  23. Kathryn Rowan20,
  24. Joel Tarning21,
  25. James A Watson21,
  26. Nicholas J White21,
  27. Edmund Juszczak22,
  28. Richard Haynes3 and
  29. Martin J Landray2,#
  1. 1Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom;
  2. 2Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom;
  3. 3MRC Population Health Research Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom;
  4. 4University Hospitals fo Leicester NHS Trust and University of Leicester;
  5. 5Regional Infectious Diseases Unit, North Manchester General Hospital & University of Manchester, Manchester, UK;
  6. 6Research and Development Department, Northampton General Hospital, Northampton, United Kingdom;
  7. 7Department of Respiratory Medicine, North Tees & Hartlepool NHS Foundation Trust, Stockton-on-Tees, United Kingdom;
  8. 8University Hospitals Birmingham NHS Foundation Trust and Institute of Microbiology & Infection, University of Birmingham, United Kingdom;
  9. 9Univeristy of Manchester and Manchester University NHS Foundation Trust, Manchester, United Kingdom;
  10. 10James Cook University Hospital, Middlesbrough, United Kingdom;
  11. 11North West Anglia NHS Foundation Trust, Peterborough, United Kingdom;
  12. 12Department of Infectious Diseases, Cardiff and Vale University Health Board; Division of Infection and Immunity, Cardiff University, Cardiff, United Kingdom;
  13. 13Roslin Institute, University of Edinburgh, Edinburgh, United Kingdom;
  14. 14School of Life Sciences, King’s College London, London, United Kingdom;
  15. 15NIHR Southampton Clinical Research Facility and Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust and University of Southampton, Southampton, United Kingdom;
  16. 16Department of Mathematics and Statistics, Lancaster University, Lancaster, United Kingdom; MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom;
  17. 17Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom;
  18. 18Respiratory Medicine Department, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom;
  19. 19School of Medicine, University of Nottingham, Nottingham, United Kingdom;
  20. 20Intensive Care National Audit & Research Centre, London, United Kingdom;
  21. 21Mahidol Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, United Kingdom;
  22. 22Nuffield Department of Population Health, University of Oxford, United Kingdom
  1. ↵#Correspondence to: Email: recoverytrial{at}ndph.ox.ac.uk
Back to top
Posted July 15, 2020.
Download PDF

Supplementary Material

Data/Code
Email
Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi-centre, randomized, controlled trial
Peter Horby, Marion Mafham, Louise Linsell, Jennifer L Bell, Natalie Staplin, Jonathan R Emberson, Martin Wiselka, Andrew Ustianowski, Einas Elmahi, Benjamin Prudon, Anthony Whitehouse, Timothy Felton, John Williams, Jakki Faccenda, Jonathan Underwood, J Kenneth Baillie, Lucy Chappell, Saul N Faust, Thomas Jaki, Katie Jeffery, Wei Shen Lim, Alan Montgomery, Kathryn Rowan, Joel Tarning, James A Watson, Nicholas J White, Edmund Juszczak, Richard Haynes, Martin J Landray
medRxiv 2020.07.15.20151852; doi: https://doi.org/10.1101/2020.07.15.20151852
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area